Cash Flow Statement

Daily Values

Growth Metrics

Others

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Interest Coverage Ratio Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales Times Interest Earned

Kairos Pharma (KAPA) Enterprise Value (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Enterprise Value for 2 consecutive years, with -$3.0 million as the latest value for Q2 2025.